Stock Price Forecast

April 19, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Akers Biosciences Inc chart...

About the Company

We do not have any company description for Akers Biosciences Inc at the moment.

Please visit http://www.akersbio.com for more information about the company.

CEO

Howard Yeaton

Exchange

NASDAQ CAPITAL MARKET

Website

http://www.akersbio.com

$2M

Total Revenue

12

Employees

$20M

Market Capitalization

-0.99

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AKER News

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

3d ago, source: Zacks.com on MSN

The market expects Arcus Biosciences, Inc. (RCUS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known ...

Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additiona...

3y ago, source: ADVFN

Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces another agreement with a major Independent ...

Arcadia Biosciences Inc RKDA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Forte Biosciences Inc Ordinary Shares FBRX

1d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Anixa Biosciences, Inc.

4mon ago, source: CNN

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following ...

PCRX Pacira BioSciences, Inc.

8d ago, source: Seeking Alpha

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in ...

Akers Ferry Canoe Rental now owned by the Blackwell family

4d ago, source: The Salem News Online

Akers Ferry Canoe Rental is now owned and operated by the Blackwell family who have been a Concessioner of the Ozark National ...

Hudson Bay Capital Management LP's Net Worth

1mon ago, source: Benzinga.com

Who is Hudson Bay Capital Management LP? Hudson Bay Capital Management LP has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include ...

Avidity Biosciences Inc

2mon ago, source: CNN

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design ...

Precision BioSciences, Inc. (DTIL)

16d ago, source: Yahoo Finance

DURHAM, N.C., April 16, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc ...

Sagimet Biosciences Inc. (SGMT)

2d ago, source: Yahoo Finance

April 22, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to ...

IGMS IGM Biosciences, Inc.

5d ago, source: Seeking Alpha

IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...